Found 7 matching trials
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer PHASE2 The purpose of this study is to identify the highest tolerable dose of pyro...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer. NA This study is a single-arm, prospective, open label clinical study for eval...
Show More Location
Multiple Locations
Learn More & Join Trial
Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer N/A This is a real world study to evaluate the efficacy and safety of inetetamb...
Show More Location
Jiangsu Provincial People's Hospital
Learn More & Join Trial
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer PHASE2 HER2-targeted therapy after the failure of trastuzumab treatment has become...
Show More Location
Sun Yat Sen Memorial Hospital,Sun Yat sen University
Learn More & Join Trial
Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer PHASE2 The purpose of this study is to identify the highest tolerable dose of pyro...
Show More Learn More & Join Trial
Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer PHASE2 In this phase 2 single-arm clinical trial, 30 patients with HER2-positive m...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS PHASE2 The objective of this Phase II, open-label, multicenter, non-randomised con...
Show More Location
Multiple Locations
Learn More & Join Trial